Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
Purpose The primary objective of this phase I/II study was to determine the safety and pharmacokinetic profile of either transfectoma- or a hybridoma-derived ipilimumab. Seconda...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 458
- Institution
- University of Arizona Cancer Center
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.